Affluent Medical | WebDisclosure

PRESS RELEASE

published on 06/24/2025 at 17:49, 9 months 2 days ago

Affluent Medical :Affluent Medical étend son horizon de trésorerie à fin 2025 avec le soutien de ses principaux actionnaires
Affluent Medical prolonge son horizon de trésorerie jusqu'à fin 2025 avec émission d'obligations convertibles de 5,4 millions d'euros par ses principaux actionnaires pour soutenir les développements cliniques et réglementaires

Actionnaires Obligations Convertibles Affluent Medical Trésorerie Développements Cliniques
BRIEF

published on 05/28/2025 at 17:50, 9 months 29 days ago

Affluent Medical: Announcement of the 2025 General Meeting

Affluent Medical Urinary Incontinence Aix-en-Provence General Meeting 2025 Medical Prosthetics
BRIEF

published on 05/28/2025 at 17:50, 9 months 29 days ago

Affluent Medical : Annonce de l'Assemblée Générale 2025

Affluent Medical Prothèses Médicales Incontinence Urinaire Aix-en-Provence Assemblée Générale 2025
PRESS RELEASE

published on 05/28/2025 at 17:45, 9 months 29 days ago

Affluent Medical : Assemblée Générale Ordinaire Annuelle et Extraordinaire du 19 juin 2025
Affluent Medical publie les modalités de participation à l'Assemblée Générale Ordinaire Annuelle et Extraordinaire du 19 juin 2025. Actionnaires invités à y participer

Assemblée Générale Affluent Medical Prothèses Médicales Maladies Cardiaques Incontinence Urinaire
BRIEF

published on 05/15/2025 at 17:50, 10 months 11 days ago

Progrès médicaux avec le dispositif Artus pour l'incontinence urinaire

Technologie Médicale Essai Clinique Médical Aisé Incontinence Urinaire Appareil Artus
BRIEF

published on 05/15/2025 at 17:50, 10 months 11 days ago

Affluent Medical Advances with Artus Device for Urinary Incontinence

Medical Technology Affluent Medical Clinical Trial Urinary Incontinence Artus Device
PRESS RELEASE

published on 05/15/2025 at 17:45, 10 months 11 days ago

Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial .
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and approval for pivotal clinical trial phase

Affluent Medical Clinical Trial Artus Urinary Sphincter Performance Results
PRESS RELEASE

published on 05/15/2025 at 17:45, 10 months 11 days ago

Affluent Medical annonce des résultats prometteurs pour son sphincter urinaire artificiel Artus et obtient l’autorisation de lancer la phase pivot de son essai clinique.
Affluent Medical annonce des r�sultats prometteurs pour son sphincter urinaire artificiel Artus et obtient l’autorisation de lancer la phase pivot de son essai clinique

Affluent Medical Essai Clinique Artus Sphincter Urinaire Dispositif M�dical
BRIEF

published on 05/15/2025 at 17:45, 10 months 11 days ago

Affluent Medical: Status of voting rights and shares as of April 30, 2025

Euronext Paris Share Capital Voting Rights Affluent Medical Medical Technologies
BRIEF

published on 05/15/2025 at 17:45, 10 months 11 days ago

Affluent Medical : État des droits de vote et actions au 30 avril 2025

Euronext Paris Droits De Vote Capital Social Affluent Medical Technologies Médicales

Published on 03/26/2026 at 23:00, 32 minutes ago

FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 1 hour 27 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 1 hour 32 minutes ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 1 hour 32 minutes ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 2 hours 32 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 2 hours 43 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 4 hours 11 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 4 hours 18 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 4 hours 22 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 4 hours 22 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

View all EQS

Published on 03/26/2026 at 18:17, 5 hours 15 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 5 hours 15 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 5 hours 32 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 5 hours 32 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 5 hours 32 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE

News